Artificial Cells Nanomedicine and Biotechnology · 2018 · 26 citations · 10 references
PharmacyPharmaceuticsPharmacologyCancer PharmacologyDrug DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineDrug EncapsulationLipid-based NanoparticlesNanomaterials For Drug DeliveryNanoparticle FormulationsAnticancer Drug LoadingCancer NanotherapyCell Viability AssaysChemotherapy DeliveryDrug Delivery NanocarriersLipid NanoparticlesLipid-based Drug CarriersNanoparticle-based Chemotherapy
Combined administration regimens are commonly used in cancer therapy to reduce cell toxicity and drug resistance. In this study, we use solid lipid nanoparticles (SLNs) as drug carriers and sought to investigate the effect of combined administration of paclitaxel (PTX) and tanespimycin (17-AAG) in gastric cancer. The SLNs loaded with paclitaxel and tanespimycin were prepared using the solvent injection method. The effect of encapsulated SLNs on cell viability and colony formation were measured in three human gastric cell lines. Cell apoptosis assay was carried out in MKN45 cells and xenograft model was used to investigate the effect of encapsulated SLNs in vitro and in vivo. The expression levels of proteins involved in oxidative stress and apoptosis were measured by western blotting analysis. The encapsulated SLNs reduced cell viabilities and colony formation in gastric cell lines. These SLNs could also induce apoptosis in MKN45 cells, inhibit growth of xenograft and influence the protein levels of Hsp90, MnSOD, Cleaved caspase 3 and Cleaved PARP. The effect of encapsulated SLNs exceeded that of single treatment of PTX or 17-AAG. The combination administration of PTX or 17-AAG resulted in a synergetic anti-cancer effect, probably via an increased oxidative stress and apoptosis levels.
10
Ellen L. Robb, Melissa M. Page, Brent Wiens et al. · Biochemical and Biophysical Research Communications · 2008 · 147 citations · Full text